Source comparison
GHK-Cu TB-500 Stack Protocol: Dosing Comparison
Phase 1 (Days 0–14) 2–5mg SC Every 3–4 days (2× weekly) 1–2mg SC Once or twice total Actin cytoskeleton reorganization, angiogenesis, endothelial migration Provisional matrix formation, re-epithelialization, vascular density Phase 2 (Days 14–42) 2–5mg SC (opti
This comparison does not assign a generated winner or score.
- Phase 1 (Days 0–14)
- 2–5mg SC
- Every 3–4 days (2× weekly)
- 1–2mg SC
- Once or twice total
- Actin cytoskeleton reorganization, angiogenesis, endothelial migration
- Provisional matrix formation, re-epithelialization, vascular density
- Phase 2 (Days 14–42)
- 2–5mg SC (optional)
- Once weekly or discontinued
- 1–3mg SC
- 3× weekly
- Collagen remodeling, MMP-2 upregulation, decorin expression
- Collagen I/III ratio normalization, tensile strength, scar reduction
- Maintenance (Days 42+)
- Discontinued
- .
- 1–2× weekly
- Matrix maintenance, anti-inflammatory signaling
- Sustained tissue quality, prevention of re-injury or degradation